Sinovac/CoronaVac Coronavirus inactivated Vaccine

From:Sinovac Biotech Ltd.(Sinovac Life Sciences)

Clinical  Stage:Phase 3

Vaccine platform:Inactivated

Type of candidate vaccine: Inactivated

Number of doses:2

Timing of doses:0,14 days

Route of Administration: IM
Phase 3 report:

Phase 1/2 report:

NCT04383574
NCT04352608
StudyReport
NCT04551547